Recombinant KIR2DL2 (Lirilumab Biosimilar) antibody
The Human Monoclonal anti-KIR2DL2 (Lirilumab Biosimilar) antibody (ABIN7538062) specifically detects KIR2DL2 (Lirilumab Biosimilar) in ELISA and WB.
The antibody is reactive with Human samples.
Catalog No. ABIN7538062
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant KIR2DL2 (Lirilumab Biosimilar) antibody (ABIN7538062)
Target
KIR2DL2 (Lirilumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This KIR2DL2 (Lirilumab Biosimilar) antibody is un-conjugated
Application
ELISA, Western Blotting (WB)
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Lirilumab Biosimilar - Anti-KIRD2 subgroup mAb - Research Grade
-
Characteristics
- Antibody Type: Human IgG1
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Purity
- > 85%
-
Isotype
- IgG
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS buffer PH7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- KIR2DL2 (Lirilumab Biosimilar)
-
Background
- Lirilumab is an anti-KIR monoclonal antibody, and shows antitumor activity. Lirilumab can be used in Leukemia, squamous cell carcinoma of the head and neck (SCCHN) research.
-
CAS-No
- 1000676-41-4
Target
-
You are here:
